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2261to make a careful distinction between SHD and CHD.
For all of us who are deeply embedded in the inter-
ventional aspects of our cardiology specialties, we
know that rich understanding of the short- and longer-
term outcomes (risks and beneﬁts) that accompany
interventions (and that require substantive experi-
ence and expertise beyond any particular technical
skillset) is paramount for optimal patient outcomes,
patient–physician trust, and innovation. Therefore,
we humbly suggest consideration of the term “non-
congenital SHD” when cardiologists mean to refer to
interventions, such as TAVR or percutaneous mitral
repair, targeted at acquired cardiac disease. Regardless
of terminology, it is important for all providers to
recognize that CHD, in children and adults, represents
an important set of cardiac diagnoses whose patients
have been demonstrated to beneﬁt greatly from well-
developed clinical and educational programs focused
on their speciﬁc disorders.Curt J. Daniels, MD
Michael J. Landzberg, MD
*Robert H. Beekman III, MD
*ACC Adult Congenital and Pediatric Cardiology Section
Division of Cardiology





Please note: All authors have reported that they have no relationships relevant
to the contents of this paper to disclose.
RE F E RENCE
1. Yadav PK, Halim SA, Vavalle JP. Training in structural heart interventions.
J Am Coll Cardiol 2014;64:2296–8.REPLY: Structural Heart Disease
Tetralogy, Transposition, and Truncus, Too?We thank Dr. Daniels and colleagues for reading
our paper (1) with interest and highlighting several
important points in their letter to the editor. We
completely agree that structural heart disease (SHD)
and congenital heart disease (CHD) are relatively
distinct specialties, and each provide care to patients
that have complex anatomy and physiology. How-
ever, we would like to acknowledge that there is some
degree of overlap between SHD and CHD, and there-
fore, it would be difﬁcult to draw lines separating
the 2. For example, transcatheter aortic valve
replacement is emerging as a good treatment option
for patients with bicuspid aortic valve stenosis who
are at high risk for surgery. This is a congenitalabnormality now being treated routinely by structural
heart disease interventionalists, often without the
assistance of adult congenital heart disease physi-
cians. This is not the only example where structural
heat disease interventionalists are now treating
congenital heart disease. Other examples include
patent foramen ovale, atrial septal defects, patent
ductus arteriosus, coronary-cameral ﬁstulas, and
others. Hence, the proposed term “non-congenital
SHD” may be misleading and not fully justiﬁable.
Certainly, congenital heart disease represents a full
spectrum of disorders, and those mentioned in the
preceding text are relatively simple defects that many
non–CHD-trained physicians would feel comfortable
treating. This is not to minimize the importance of the
role for interventional CHD specialists, where their
expertise is needed in the treatment of complex de-
fects such as tetralogy of Fallot, transposition of the
great arteries, and truncus arteriosus, among many
others. Hence, adult congenital heart disease (ACHD)
patients are best treated by dedicated specialists who
understand these disease processes well and can
provide invasive and non-invasive therapies as and
when needed. As Daniels et al. pointed-out, ACHD
has a dedicated fellowship track with an American
Board of Internal Medicine board certiﬁcation that
can be pursued after general cardiology or pediatric
cardiology and is its own specialty dedicated to the
care of these patients.
It is time to tear down the silos within medicine
and not build new ones. These complex patients
require a team approach and the expertise of
diversely trained specialists. We should capitalize on
each other’s skill set and work within each other’s
training limitations. We should move away from this
sentiment of deciding which patients are “yours” and
which are “mine.” They all belong to all of us. This is
exactly what SHD has re-emphasized in our medical
practice, more than ever before. Like Dr. Holmes and
Dr. Mack commented in their response to our original
letter, these complex procedures have helped in
breaking some of the artiﬁcially erected silos between
different specialties. Both structural and congenital
heart disease could be considered as 2 ends of the
spectrum, each with its own unique area of expertise,
but with some common shared space; and for this
space, working together will give our patients the
best possible outcomes.*Pradeep K. Yadav, MD
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and Dilation
Inﬂuence on Coronary
Supply–Demand BalanceWe read with great interest the article by Redheuil
et al. (1), which reported that proximal aortic disten-
sibility was an independent predictor of all-cause
mortality and incidence of further cardiovascular
events. Concerning congenital heart diseases, there
are lots of reports about the decreased distensibility of
native and post-operative aortas. We previously re-
ported the decreased ascending aortic distensibility in
patients with transposition of the great arteries after
arterial switch procedure (2). The decreased aortic
distensibility increases the afterload of the left
ventricle and is a disadvantage for coronary circulation
(3). Therefore, we also examined the subendocardial
viability ratio in those patients (4). The subendocardial
viability ratio is the ratio of the aortic diastolic pressure
time integral and the aortic systolic pressure time in-
tegral (tension time index), that is, a measure of he-
modynamic capacity for supply divided by myocardial
oxygen demand. In that study, the tension time index,
which indicates the myocardial oxygen demand, was
higher than that in the control subjects, although the
subendocardial viability ratio was the same. This
pattern of the aortic pressure waveform, an elevated
tension time index without a decrease of the sub-
endocardial viability ratio, is similar to that in elderly
people, although the patients in our study were
elementary school–aged children.
Because preserving the coronary supply–demand
balance is essential to sustain life, the subendocardial
viability ratio should be maintained constant even
in conditions with decreased aortic distensibility.
Because the decreased aortic distensibility increases
left ventricular workload, it is necessary to increase
“supply,” although the stiff aorta is a disadvantage
for coronary circulation (3). In our opinion, 1 of the
solutions to the problem is aortic dilation. Althoughthe aortic distensibility is decreased, an expanded
aorta may be able to store enough blood during sys-
tole, which resembles the compensation of a failing
heart; that is, although the left ventricular ejection
fraction is decreased, the increased left ventricular
end-diastolic volume can maintain sufﬁcient cardiac
output. Actually, our patients demonstrated aortic
dilation (2) (so-called “aortopathy” in congenital
heart diseases [5]). In addition, it is well known that
the aortas in elderly people are not only stiff, but also
dilated (3).
We would like to know whether the aortic diameter
was related to its distensibility in Redheuil et al.’s
study (1). Moreover, we are interested in the sub-
endocardial viability ratio and the tension time index
of the patients in their study.*Tomoaki Murakami, MD, PhD
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Inﬂuence on Coronary Supply–Demand BalanceWe wish to thank Drs. Murakami and Niwa for their
interest in our work and their very insightful com-
ments. Concerning congenital heart disease, in
particular arterial switch for transposition of the great
arteries correction, we agree that altered myocardial
oxygen supply is multifactorial and that the proximal
aorta may play a role in several ways. First, the
evolution and aging of the neoaorta-associating dila-
tion, elongation, and rotation processes may lead to
